- Home
- AGIG vs DXR Comparison
AGIG vs DXR Comparison
Compare AGIG & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AGIG | DXR |
|---|---|---|
| Founded | N/A | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 54.3M | 59.0M |
| IPO Year | 2025 | 1995 |
Fundamental Metrics
Financial Performance| Metric | AGIG | DXR |
|---|---|---|
| Price | $0.92 | $10.30 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | ★ 117.4K | 33.2K |
| Earning Date | 11-18-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $410,632.00 | ★ $1,446,345.00 |
| Revenue This Year | $1,896.92 | $44,489.33 |
| Revenue Next Year | $21.95 | $74.79 |
| P/E Ratio | ★ N/A | $33.83 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.83 | $8.56 |
| 52 Week High | $5.31 | $14.76 |
Technical Indicators
Market Signals| Indicator | AGIG | DXR |
|---|---|---|
| Relative Strength Index (RSI) | 37.77 | 42.40 |
| Support Level | $0.86 | $10.28 |
| Resistance Level | $1.10 | $10.99 |
| Average True Range (ATR) | 0.10 | 0.63 |
| MACD | -0.03 | -0.12 |
| Stochastic Oscillator | 6.64 | 15.43 |
Price Performance
Historical ComparisonAbout AGIG Abundia Global Impact Group Inc. Common stock
Abundia Global Impact Group Inc. is a technology solutions company operating in recycling, renewable energy, environmental change, fuels, and chemicals sectors, mainly focused on low-carbon energy solutions. The company uses waste plastics and biomass to produce crude or drop-in alternatives to fossil-derived energy, fuels, and chemicals through proprietary, licensed, and commercialized technologies, forming a complete process. It operates through its subsidiary and integrates feedstocks, technology, and off-take partners into a complete commercial chain. Its segments include Oil and Gas (O&G), which generates maximum revenue, and Renewables, which consists of its low-carbon fuels and renewable chemicals business.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system.